Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.72 USD | +4.32% | +0.52% | -12.38% |
03-18 | Forte Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01-05 | Camac Partners Provides Information to Shareholders | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.38% | 25.12M | |
-1.94% | 103B | |
+7.00% | 101B | |
+4.40% | 23.07B | |
-11.98% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.73% | 16.94B | |
+5.82% | 14.07B | |
+37.93% | 12.35B |
- Stock Market
- Equities
- FBRX Stock
- News Forte Biosciences, Inc.
- Forte Biosciences : Chardan Capital Adjusts Price Target on Forte Biosciences to $105 From $115, Maintains Buy Rating